Health and Me

Tanya Dutt

WHO Issues Recommendations To Fight RSV In Babies- How Parents Can Protect Their Newborns

The World Health Organization (WHO) has issued its first-ever immunization recommendations against Respiratory Syncytial Virus (RSV) — a common but potentially deadly respiratory infection that disproportionately affects newborns and young children. With RSV accounting for nearly 100,000 deaths and over 3.6 million hospitalizations annually among children under five, these new guidelines come as a much-needed global health intervention, especially in low- and middle-income countries where access to oxygen and hydration remains limited.

As international attention shifts toward this preventable yet dangerous illness, WHO’s new recommendations bring renewed hope for parents and caregivers — offering medically backed, preventive tools that could significantly reduce RSV-related hospitalizations and infant mortality worldwide.

Though RSV may mimic the common cold in many cases, its effects in infants can be devastating. The virus is highly contagious and particularly dangerous for babies under six months, especially those born prematurely or with weakened immune systems. What begins as a mild cough or runny nose can escalate to pneumonia or bronchiolitis, requiring urgent hospitalization.

Dr. Kate O’Brien, Director of Immunization, Vaccines, and Biologicals at WHO, explains, “RSV is an incredibly infectious virus that infects people of all ages, but is especially harmful to infants, particularly those born premature, when they are most vulnerable to severe disease.”

Despite its massive global impact, RSV has been largely underprioritized in global health discussions — until now.

<h2>WHO’s First Global Immunization Guidance on RSV</h2>

In a new and landmark position paper released on May 30, 2025, WHO introduced its first comprehensive immunization guidance to protect infants from RSV. The document outlines two key immunization products:

<ul><li>RSVpreF Maternal Vaccine</li><li>Nirsevimab Monoclonal Antibody Injection</li></ul>

These immunizations were recommended for global use by the Strategic Advisory Group of Experts on Immunization (SAGE) in September 2024. The maternal vaccine also received WHO prequalification in March 2025 — a move that allows UN agencies and global health funders to begin procurement and deployment across nations.

This scientific breakthrough represents more than just a pharmaceutical advance. It marks a strategic turning point in pediatric health — a chance to proactively prevent rather than react to one of the leading causes of infant respiratory distress and death.

The RSVpreF maternal vaccine is designed for administration during the third trimester of pregnancy, ideally from the 28th week onwards. Administered during routine antenatal check-ups, the vaccine prompts the mother’s immune system to produce RSV-specific antibodies, which are then transferred to the fetus through the placenta.

This passive immunity equips the newborn with a layer of defense right from birth, a critical window of vulnerability when babies are most at risk of severe RSV outcomes.

Maternal immunization is especially beneficial in countries where healthcare access is limited post-delivery, offering early protection before the baby can be brought to pediatric check-ups or immunization visits.

<h2>How Does Monoclonal Antibody Protection Works?</h2>

Nirsevimab, the second recommended intervention, is a monoclonal antibody administered as a single injection shortly after birth or before hospital discharge. For infants not vaccinated at birth, the antibody can be administered during the first health check-up or just before RSV season begins — especially relevant in regions where RSV follows seasonal patterns.

Unlike traditional vaccines that train the body to build its own immune response, monoclonal antibodies provide immediate protection. A single dose can protect infants for at least five months — long enough to cover an entire RSV season.

WHO emphasizes that the greatest benefit will be seen in babies under six months of age, though infants up to 12 months may also derive protective benefits.

According to WHO, 97% of RSV-related infant deaths occur in low- and middle-income countries — largely due to a lack of timely medical care like oxygen therapy or intravenous hydration. The rollout of these preventive tools offers these regions an unprecedented opportunity to fight RSV on the frontlines.

These immunization products can also significantly reduce hospital burden in high-income countries, freeing up pediatric intensive care units (ICUs) and reducing parental anxiety during RSV season.

The WHO’s position paper is not only a scientific guide — it's a strategic blueprint for governments, health ministries, and funding agencies to incorporate RSV prevention into national immunization programs.

<h2>What Parents Can Do to Protect Their Newborns From RSV?</h2>

While global immunization strategies are being rolled out, individual parents still play a crucial role in protecting their newborns from RSV. Here's how:

<h4>1. Ask About Maternal Vaccination During Pregnancy</h4>

If you’re pregnant, speak with your healthcare provider about receiving the RSVpreF vaccine during your third trimester. It can be safely administered as part of your regular antenatal care, and offers vital early protection to your newborn.

<h4>2. Ensure Timely Infant Immunization</h4>

If the monoclonal antibody nirsevimab is available in your country, ensure your baby receives the injection either at birth or during their first pediatric visit. In areas with seasonal RSV peaks, schedule the dose ahead of the expected surge.

<h4>3. Limit Infant Exposure During RSV Season</h4>

Avoid crowded public places during RSV season, especially with newborns. RSV spreads through respiratory droplets and contaminated surfaces, making indoor public gatherings a high-risk environment.

<h4>4. Practice Hand Hygiene and Clean Surfaces</h4>

Ensure everyone who comes into contact with your baby washes their hands thoroughly. Disinfect frequently touched surfaces — RSV can survive on hard surfaces for hours.

If your baby shows signs of difficulty breathing, rapid breathing, persistent cough, or a bluish tint around the lips or fingernails, seek immediate medical attention. RSV can escalate quickly in infants.

With WHO’s endorsement of two powerful preventive options, RSV no longer needs to be a silent killer. The combination of maternal vaccination and infant monoclonal antibodies brings renewed hope to millions of parents — especially those in under-resourced areas — who’ve long been without any effective preventive tools.

As Dr. O’Brien puts it, “The WHO-recommended RSV immunization products can transform the fight against severe RSV disease, dramatically reduce hospitalizations, and deaths, ultimately saving many infant lives globally.”

Health Conditions A-Z

health

rsv in infants

who rsv guidelines

rsv vaccine for newborns

nirsevimab for babies

maternal rsv vaccine

protect newborns from rsv

rsv prevention 2025

World Environment Day 2025: Everyday Habits That Are Harming The Earth And Your Health

New COVID-19 Variants Are Not Serious Threats, Say Doctors

World Environmental Day 2025: How Green Therapy Can Help You Lower Anxiety And Depression

Health News

Do Changing Seasons Affect Your Weight?

Can Heatwave Affect Your Diet?

Heatwave To Monsoon: Health Concerns With Seasonal Changes

Standing Exercises That Help You Burn Calories

Reasons To Do Dancing As A Workout

Why Summer Fruits Are A Great Addition To Your Diet?

What Should You Avoid For Your Bladder?

Lower-Body Exercises For Strong Foundation

Healthy Drinks That Improve Your Digestion

World Tobacco Day: Unexpected Ways Smoking Can Affect You

Seasonal Mood Swings? How Weather Affects Mental Health

Is Calorie Counting Healthy? Dos And Don’ts

Heat-Related Illnesses That You Should Know

Menstrual Hygiene Day: Tips On Period Hygiene

​Add These High Protein Vegetarian Meals To Your Diet​

Top 10 Workouts That Burn Most Calorie

Makhana Season – Healthy &amp; Quick Foxnut Recipes

Monsoon Ahead – Tips On Building Rainy Season Immunity

Do You Have Prickly Heat Rash – Symptoms, Causes And Treatment

Healthy No-Cook Recipes You Can Try

How Do You Calorie Count – Numbers And Nutrients

Unexpected Signs Of Dehydration – Safety And Precaution Measures

Leg Exercises You Can Do At Home To Build Strength

Foods That Promote Skin Elasticity

Must-Do Chest Exercises You Can Try At Home

What Are The Symptoms Of JN.1 COVID-19 Strain?

Why Does Sleeping Become Harder As You Age?

High-Fiber Healthy Drinks You Should Try

10 Dumbbell Exercise Variations For Upper-Body Strength

A Parent’s Guide To Pets: Important Points To Consider For Your Child’s Health

Food Anxiety Is Real – How Your Food Intake Affects Your Anxiety

World Osteoporosis Month: Ways To Strengthen Your Bones

Brain Exercises To Keep You Cognitively Sharp

Easy Recipes To Make When You Don’t Wish To Cook

Physical Signs Of High Cortisol

9 Healthy Plant-Based Protein Rich Dishes To Try

What Happens When You Have Low Blood Pressure?

Throw These Toxic Bathroom Items Away To Protect Your Health

This Is What Cricket Superstar Virat Kohli Eats In A Day

Signs You Are Experiencing Sensory Overload

The World Health Organization (WHO) has issued its first-ever immunization recommendations against Respiratory Syncytial Virus (RSV) — a common but potentially deadly respiratory infection that disproportionately affects newborns and young children. With RSV accounting for nearly 100,000 deaths and over 3.6 million hospitalizations annually among children under five, these new guidelines come as a much-needed global health intervention, especially in low- and middle-income countries where access to oxygen and hydration remains limited.As international attention shifts toward this preventable yet dangerous illness, WHO’s new recommendations bring renewed hope for parents and caregivers — offering medically backed, preventive tools that could significantly reduce RSV-related hospitalizations and infant mortality worldwide.Though RSV may mimic the common cold in many cases, its effects in infants can be devastating. The virus is highly contagious and particularly dangerous for babies under six months, especially those born prematurely or with weakened immune systems. What begins as a mild cough or runny nose can escalate to pneumonia or bronchiolitis, requiring urgent hospitalization.Dr. Kate O’Brien, Director of Immunization, Vaccines, and Biologicals at WHO, explains, “RSV is an incredibly infectious virus that infects people of all ages, but is especially harmful to infants, particularly those born premature, when they are most vulnerable to severe disease.”Despite its massive global impact, RSV has been largely underprioritized in global health discussions — until now.WHO’s First Global Immunization Guidance on RSVIn a new and landmark position paper released on May 30, 2025, WHO introduced its first comprehensive immunization guidance to protect infants from RSV. The document outlines two key immunization products:RSVpreF Maternal VaccineNirsevimab Monoclonal Antibody InjectionThese immunizations were recommended for global use by the Strategic Advisory Group of Experts on Immunization (SAGE) in September 2024. The maternal vaccine also received WHO prequalification in March 2025 — a move that allows UN agencies and global health funders to begin procurement and deployment across nations.This scientific breakthrough represents more than just a pharmaceutical advance. It marks a strategic turning point in pediatric health — a chance to proactively prevent rather than react to one of the leading causes of infant respiratory distress and death.What is Maternal Immunization?The RSVpreF maternal vaccine is designed for administration during the third trimester of pregnancy, ideally from the 28th week onwards. Administered during routine antenatal check-ups, the vaccine prompts the mother’s immune system to produce RSV-specific antibodies, which are then transferred to the fetus through the placenta.This passive immunity equips the newborn with a layer of defense right from birth, a critical window of vulnerability when babies are most at risk of severe RSV outcomes.Maternal immunization is especially beneficial in countries where healthcare access is limited post-delivery, offering early protection before the baby can be brought to pediatric check-ups or immunization visits.How Does Monoclonal Antibody Protection Works?Nirsevimab, the second recommended intervention, is a monoclonal antibody administered as a single injection shortly after birth or before hospital discharge. For infants not vaccinated at birth, the antibody can be administered during the first health check-up or just before RSV season begins — especially relevant in regions where RSV follows seasonal patterns.Unlike traditional vaccines that train the body to build its own immune response, monoclonal antibodies provide immediate protection. A single dose can protect infants for at least five months — long enough to cover an entire RSV season.WHO emphasizes that the greatest benefit will be seen in babies under six months of age, though infants up to 12 months may also derive protective benefits.According to WHO, 97% of RSV-related infant deaths occur in low- and middle-income countries — largely due to a lack of timely medical care like oxygen therapy or intravenous hydration. The rollout of these preventive tools offers these regions an unprecedented opportunity to fight RSV on the frontlines.These immunization products can also significantly reduce hospital burden in high-income countries, freeing up pediatric intensive care units (ICUs) and reducing parental anxiety during RSV season.The WHO’s position paper is not only a scientific guide — it's a strategic blueprint for governments, health ministries, and funding agencies to incorporate RSV prevention into national immunization programs.What Parents Can Do to Protect Their Newborns From RSV?While global immunization strategies are being rolled out, individual parents still play a crucial role in protecting their newborns from RSV. Here's how:1. Ask About Maternal Vaccination During PregnancyIf you’re pregnant, speak with your healthcare provider about receiving the RSVpreF vaccine during your third trimester. It can be safely administered as part of your regular antenatal care, and offers vital early protection to your newborn.2. Ensure Timely Infant ImmunizationIf the monoclonal antibody nirsevimab is available in your country, ensure your baby receives the injection either at birth or during their first pediatric visit. In areas with seasonal RSV peaks, schedule the dose ahead of the expected surge.3. Limit Infant Exposure During RSV SeasonAvoid crowded public places during RSV season, especially with newborns. RSV spreads through respiratory droplets and contaminated surfaces, making indoor public gatherings a high-risk environment.4. Practice Hand Hygiene and Clean SurfacesEnsure everyone who comes into contact with your baby washes their hands thoroughly. Disinfect frequently touched surfaces — RSV can survive on hard surfaces for hours.5. Watch for Warning SignsIf your baby shows signs of difficulty breathing, rapid breathing, persistent cough, or a bluish tint around the lips or fingernails, seek immediate medical attention. RSV can escalate quickly in infants.With WHO’s endorsement of two powerful preventive options, RSV no longer needs to be a silent killer. The combination of maternal vaccination and infant monoclonal antibodies brings renewed hope to millions of parents — especially those in under-resourced areas — who’ve long been without any effective preventive tools.As Dr. O’Brien puts it, “The WHO-recommended RSV immunization products can transform the fight against severe RSV disease, dramatically reduce hospitalizations, and deaths, ultimately saving many infant lives globally.”

who issues recommendations to fight rsv in babies- how parents can protect their newborns

Ishita Roy

Trump Administration's Ban On Emergency Abortion Could Jeopardize Women’s Health

Against Medical Evidence, Louisiana Lawmakers Deny Abortion Access To Rape Victims

against medical evidence, louisiana lawmakers deny abortion access to rape victims

Health & Wellness

CDC Contradicts RFK Jr. On Immunization For Kids Amid COVID Vaccine Changes, Confusion And Misinformation

cdc contradicts rfk jr. on immunization for kids amid covid vaccine changes, confusion and misinformation

How A Pregnant Woman’s Weight Affects Her Baby's Risk For Infections?

how a pregnant woman’s weight affects her baby's risk for infections?

As legal battles around <span>abortion</span> continue in the United States, the <span>Trump</span> administration has announced plans to revoke federal guidance that currently protects access to emergency abortions in hospitals. The move targets a 2022 directive from the Biden administration that was rooted in the Emergency Medical Treatment and Active Labor Act (EMTALA)—a federal law that mandates emergency care, including when pregnancy complications threaten a woman’s life.

This potential reversal is more than a political maneuver—it could pose serious risks to patients' health and further strain hospital decision-making.

<h4>What Is EMTALA and Why It Matters</h4>

Enacted in 1986, the Emergency Medical Treatment and Active Labor Act (EMTALA) requires that hospitals accepting Medicare funds must offer a medical screening exam and stabilizing treatment to any patient who arrives at the emergency room, regardless of their ability to pay.

In 2022, citing EMTALA, the Biden administration clarified that <span>emergency abortion</span> care falls within the scope of stabilizing treatment when a pregnancy threatens the mother’s life or health. That meant hospitals were legally obligated to provide abortions in such emergencies—even in states where abortion was otherwise banned.

The Trump administration’s proposed rollback would mean that the federal government will no longer enforce this interpretation, leaving hospitals in abortion-restrictive states with unclear guidance. In its recent statement, the Centers for Medicare &amp; Medicaid Services claimed it would still enforce EMTALA protections, but critics argue that without explicitly including abortion care, pregnant patients may be left in legal limbo during critical medical crises.

<h4>Health Risks of Denied Emergency Abortions</h4>

When abortion is denied in life-threatening cases, the medical fallout can be devastating. Conditions like preeclampsia, ectopic pregnancy, and severe hemorrhaging often require immediate termination of pregnancy to save a woman’s life. Delay or denial can result in organ failure, long-term disability, or even death.

A 2019 study titled They Are Girls, Not Mothers underscores the gravity of forced pregnancy, especially among adolescents. It cites risks such as preterm labor and maternal death, which are significantly higher in teenagers. Globally, pregnancy and childbirth remain the leading cause of death for girls aged 15 to 19.

Additionally, survivors of sexual violence—many of them minors—often face traumatic and subpar medical treatment. In some countries, like Guatemala and Nicaragua, young rape survivors are subjected to unnecessary Caesarean sections due to a lack of provider training. These surgeries can have lifelong implications, including chronic pain, fertility issues, and psychological trauma.

Beyond physical health, forced pregnancy has severe mental and emotional consequences. The Silenced Lives report found a link between forced motherhood and suicide among teenage girls. In one case, a pregnant girl named Juana from Guatemala said, “I want to die; my heart is not happy like before.”

The social implications are equally damaging. Teenage mothers are more likely to drop out of school, miss career opportunities, and fall into poverty. According to the Stolen Lives report, 33% of affected girls only reached primary education. Many are pulled out of classrooms, removed from peer groups, and pushed into adult responsibilities they are unprepared for.

Revoking emergency abortion protections under EMTALA doesn’t just impact legal rights—it creates confusion in emergency rooms and jeopardizes patient safety. Medical staff could be forced to choose between following state abortion bans and offering life-saving care. For pregnant patients in crisis, that legal uncertainty could mean the difference between life and death.

With the Trump administration’s rollback, the future of emergency reproductive care in America remains dangerously uncertain.

US health

emergency abortion ban impact

Trump bans emergency abortion

health news

abortion

abortion ban

emergency abortion

women's health

reproductive health

Trump

As legal battles around abortion continue in the United States, the Trump administration has announced plans to revoke federal guidance that currently protects access to emergency abortions in hospitals. The move targets a 2022 directive from the Biden administration that was rooted in the Emergency Medical Treatment and Active Labor Act (EMTALA)—a federal law that mandates emergency care, including when pregnancy complications threaten a woman’s life.This potential reversal is more than a political maneuver—it could pose serious risks to patients' health and further strain hospital decision-making.What Is EMTALA and Why It MattersEnacted in 1986, the Emergency Medical Treatment and Active Labor Act (EMTALA) requires that hospitals accepting Medicare funds must offer a medical screening exam and stabilizing treatment to any patient who arrives at the emergency room, regardless of their ability to pay.In 2022, citing EMTALA, the Biden administration clarified that emergency abortion care falls within the scope of stabilizing treatment when a pregnancy threatens the mother’s life or health. That meant hospitals were legally obligated to provide abortions in such emergencies—even in states where abortion was otherwise banned.The Trump administration’s proposed rollback would mean that the federal government will no longer enforce this interpretation, leaving hospitals in abortion-restrictive states with unclear guidance. In its recent statement, the Centers for Medicare & Medicaid Services claimed it would still enforce EMTALA protections, but critics argue that without explicitly including abortion care, pregnant patients may be left in legal limbo during critical medical crises.Health Risks of Denied Emergency AbortionsWhen abortion is denied in life-threatening cases, the medical fallout can be devastating. Conditions like preeclampsia, ectopic pregnancy, and severe hemorrhaging often require immediate termination of pregnancy to save a woman’s life. Delay or denial can result in organ failure, long-term disability, or even death.A 2019 study titled They Are Girls, Not Mothers underscores the gravity of forced pregnancy, especially among adolescents. It cites risks such as preterm labor and maternal death, which are significantly higher in teenagers. Globally, pregnancy and childbirth remain the leading cause of death for girls aged 15 to 19.Additionally, survivors of sexual violence—many of them minors—often face traumatic and subpar medical treatment. In some countries, like Guatemala and Nicaragua, young rape survivors are subjected to unnecessary Caesarean sections due to a lack of provider training. These surgeries can have lifelong implications, including chronic pain, fertility issues, and psychological trauma.Mental and Social ConsequencesBeyond physical health, forced pregnancy has severe mental and emotional consequences. The Silenced Lives report found a link between forced motherhood and suicide among teenage girls. In one case, a pregnant girl named Juana from Guatemala said, “I want to die; my heart is not happy like before.”The social implications are equally damaging. Teenage mothers are more likely to drop out of school, miss career opportunities, and fall into poverty. According to the Stolen Lives report, 33% of affected girls only reached primary education. Many are pulled out of classrooms, removed from peer groups, and pushed into adult responsibilities they are unprepared for.A Crisis of CareRevoking emergency abortion protections under EMTALA doesn’t just impact legal rights—it creates confusion in emergency rooms and jeopardizes patient safety. Medical staff could be forced to choose between following state abortion bans and offering life-saving care. For pregnant patients in crisis, that legal uncertainty could mean the difference between life and death.With the Trump administration’s rollback, the future of emergency reproductive care in America remains dangerously uncertain.

trump administration's ban on emergency abortion could jeopardize women’s health

New COVID Variant NB.1.8.1 Confirmed In UK: What Are The Unusual Symptoms You Must Know?

new covid-19 variants are not serious threats, say doctors

Monsoon Health Alert: Common Waterborne Diseases You Need To Watch Out For This Rainy Season

monsoon health alert: common waterborne diseases you need to watch out for this rainy season

Nutrition

FDA Issues Severe Tomato Recall Warning in Southern US

fda issues severe tomato recall warning in southern us

Know All About The Candidozyma Auris, The Fungal Pathogen And A Rising Health Threat

know all about the candidozyma auris, the fungal pathogen and a rising health threat

The COVID-19 pandemic may feel like a chapter we’re slowly closing, but the virus continues to evolve, reminding us that the story is far from over. A new variant of the virus, NB.1.8.1, has recently been confirmed in the United Kingdom and is steadily appearing in various parts of the world—including the United States, Australia, Thailand, and parts of Asia and North Africa. First detected in January 2025, the Omicron subvariant has now become a global phenomenon, leading health officials to release new advisories, especially for travelers.

NB.1.8.1 is a new sublineage of the Omicron family, which has been the leading group of SARS-CoV-2 variants for several years. While it initially appeared in genetic surveillance data at the beginning of 2025, confirmed cases began to emerge more noticeably by April. It has been officially declared by the World Health Organization (WHO) as a "variant under monitoring," noting its rising rate of detection and susceptibility to avoiding immunity elicited from past infections or vaccination.

Today, NB.1.8.1 accounts for around 10.7% of all sequenced infections worldwide. Seven confirmed cases have appeared in Northern Ireland alone in the UK, and experts are monitoring its spread very closely. Its increasing circulation quickly has also brought questions regarding its behavior, contagiousness, and—most particularly—its symptoms.

Following virologists and evidence from GISAID, NB.1.8.1 could have an increased capacity to infect human cells more effectively compared to some of its Omicron ancestors. This doesn't always mean it is more severe, but it will make the variant more infectious, particularly in densely populated indoor environments or areas where immunity is low.

The WHO has underscored that variant dynamics have also changed significantly since the start of 2025. Previously prevalent strains such as XEC and LP.8.1 are now being replaced by NB.1.8.1, particularly in places such as China and Hong Kong where this subvariant has rapidly emerged as dominant.

<h2>What Makes NB.1.8.1 Symptoms Different?</h2>

Although most symptoms are similar to other COVID-19 strains, the distinguishing factor of NB.1.8.1 is that it is more likely to cause gastrointestinal symptoms. Evidence in the UK and forthcoming international data suggest an uptick in cases presenting with symptoms of:

<ul><li>Diarrhea</li><li>Constipation</li><li>Nausea or vomiting</li><li>Abdominal pain and bloating</li><li>Heartburn</li></ul>

These symptoms, though not entirely novel to COVID-19, are increasingly being reported in NB.1.8.1 cases. This change is leading experts to encourage physicians and patients to be sensitive to digestive complaints that might otherwise be misdiagnosed as foodborne illness or a stomach bug.

<h2>Recognizing The Unusual Symptoms of NB.1.8.1</h2>

Besides gastrointestinal distress, the NB.1.8.1 variant may also exhibit a broad spectrum of respiratory and systemic symptoms:

<ul><li>High temperature or chills</li><li>Coughing that doesn't go away</li><li>Breathing that is short</li><li>Loss or change of smell and taste</li><li>Sore throat</li><li>Headache</li><li>Aching of muscles</li><li>Runny nose or congestion</li><li>Fatigue</li><li>Loss of appetite</li></ul>

Note that although the occurrence of uncommon gastrointestinal symptoms could be used to distinguish NB.1.8.1, the majority of cases still mimic typical presentations of COVID-19. Therefore, proper diagnosis via testing is still vital.

<h2>Is the New Variant More Dangerous?</h2>

To date, there is no indication that NB.1.8.1 causes more serious illness or greater hospitalization than other Omicron subvariants. Nevertheless, its efficiency in spreading and in exhibiting symptoms that will not necessarily lead to COVID testing is a variant to monitor.

Immunologists are most interested in how it has the ability to partially evade immunity, something which could cause more breakthrough infections within vaccinated or previously infected people. 

<h2>What Are The Precautions Travelers Must Take?</h2>

For tourists, particularly to countries with an upsurge of NB.1.8.1 infections such as the US, Australia, Egypt, the Maldives, and Southeast Asia, caution is the word. Although there are no fresh travel restrictions or bans introduced, public health officials suggest a number of precautionary measures:

<ul><li>Be aware of local COVID-19 guidelines at your destination.</li><li>Bring lateral flow tests and masks, especially while moving about airports or using public transportation.</li><li>Practise diligent hand hygiene and limit time in enclosed or crowded spaces.</li><li>Consider COVID-specific travel insurance, covering cancellations or health emergencies abroad.</li><li>Monitor your health and delay travel if symptomatic.</li><li>Travelers from the UK, in particular, are being urged to remain alert and informed as NB.1.8.1 spreads in popular vacation destinations.</li></ul>

Even as COVID-19 has become part of the everyday background, NB.1.8.1 is a reminder that the virus remains in motion. For high-risk groups—the elderly or immunocompromised—the threat is still real, and so is the call for public health awareness.

NB.1.8.1 isn't seen as more fatal, but its spreading and uncharacteristic symptoms render it a virus that requires concern, not hysteria. It all comes down to being informed, being aware of symptoms, particularly those that may sense unusual and taking preventative health care when abroad or ill.

nb.1.8.1 covid variant

strange covid symptoms

unusual covid signs

new covid strain 2025

gastrointestinal covid symptoms

omicron subvariant nb.1.8.1

covid variant in uk

The COVID-19 pandemic may feel like a chapter we’re slowly closing, but the virus continues to evolve, reminding us that the story is far from over. A new variant of the virus, NB.1.8.1, has recently been confirmed in the United Kingdom and is steadily appearing in various parts of the world—including the United States, Australia, Thailand, and parts of Asia and North Africa. First detected in January 2025, the Omicron subvariant has now become a global phenomenon, leading health officials to release new advisories, especially for travelers.NB.1.8.1 is a new sublineage of the Omicron family, which has been the leading group of SARS-CoV-2 variants for several years. While it initially appeared in genetic surveillance data at the beginning of 2025, confirmed cases began to emerge more noticeably by April. It has been officially declared by the World Health Organization (WHO) as a "variant under monitoring," noting its rising rate of detection and susceptibility to avoiding immunity elicited from past infections or vaccination.Today, NB.1.8.1 accounts for around 10.7% of all sequenced infections worldwide. Seven confirmed cases have appeared in Northern Ireland alone in the UK, and experts are monitoring its spread very closely. Its increasing circulation quickly has also brought questions regarding its behavior, contagiousness, and—most particularly—its symptoms.How Does NB.1.8.1 Spread?Following virologists and evidence from GISAID, NB.1.8.1 could have an increased capacity to infect human cells more effectively compared to some of its Omicron ancestors. This doesn't always mean it is more severe, but it will make the variant more infectious, particularly in densely populated indoor environments or areas where immunity is low.The WHO has underscored that variant dynamics have also changed significantly since the start of 2025. Previously prevalent strains such as XEC and LP.8.1 are now being replaced by NB.1.8.1, particularly in places such as China and Hong Kong where this subvariant has rapidly emerged as dominant.What Makes NB.1.8.1 Symptoms Different?Although most symptoms are similar to other COVID-19 strains, the distinguishing factor of NB.1.8.1 is that it is more likely to cause gastrointestinal symptoms. Evidence in the UK and forthcoming international data suggest an uptick in cases presenting with symptoms of:DiarrheaConstipationNausea or vomitingAbdominal pain and bloatingHeartburnThese symptoms, though not entirely novel to COVID-19, are increasingly being reported in NB.1.8.1 cases. This change is leading experts to encourage physicians and patients to be sensitive to digestive complaints that might otherwise be misdiagnosed as foodborne illness or a stomach bug.Recognizing The Unusual Symptoms of NB.1.8.1Besides gastrointestinal distress, the NB.1.8.1 variant may also exhibit a broad spectrum of respiratory and systemic symptoms:High temperature or chillsCoughing that doesn't go awayBreathing that is shortLoss or change of smell and tasteSore throatHeadacheAching of musclesRunny nose or congestionFatigueLoss of appetiteNote that although the occurrence of uncommon gastrointestinal symptoms could be used to distinguish NB.1.8.1, the majority of cases still mimic typical presentations of COVID-19. Therefore, proper diagnosis via testing is still vital.Is the New Variant More Dangerous?To date, there is no indication that NB.1.8.1 causes more serious illness or greater hospitalization than other Omicron subvariants. Nevertheless, its efficiency in spreading and in exhibiting symptoms that will not necessarily lead to COVID testing is a variant to monitor.Immunologists are most interested in how it has the ability to partially evade immunity, something which could cause more breakthrough infections within vaccinated or previously infected people. What Are The Precautions Travelers Must Take?For tourists, particularly to countries with an upsurge of NB.1.8.1 infections such as the US, Australia, Egypt, the Maldives, and Southeast Asia, caution is the word. Although there are no fresh travel restrictions or bans introduced, public health officials suggest a number of precautionary measures:Be aware of local COVID-19 guidelines at your destination.Bring lateral flow tests and masks, especially while moving about airports or using public transportation.Practise diligent hand hygiene and limit time in enclosed or crowded spaces.Consider COVID-specific travel insurance, covering cancellations or health emergencies abroad.Monitor your health and delay travel if symptomatic.Travelers from the UK, in particular, are being urged to remain alert and informed as NB.1.8.1 spreads in popular vacation destinations.Even as COVID-19 has become part of the everyday background, NB.1.8.1 is a reminder that the virus remains in motion. For high-risk groups—the elderly or immunocompromised—the threat is still real, and so is the call for public health awareness.NB.1.8.1 isn't seen as more fatal, but its spreading and uncharacteristic symptoms render it a virus that requires concern, not hysteria. It all comes down to being informed, being aware of symptoms, particularly those that may sense unusual and taking preventative health care when abroad or ill.

new covid variant nb.1.8.1 confirmed in uk: what are the unusual symptoms you must know?

Pop Star Jessie J Diagnosed With  Early-Stage Breast Cancer; What Are The Signs Women Often Ignore?

Don’t Wait! Why Women In Their 40s Should Prioritize Breast Cancer Screening Now

don’t wait! why women in their 40s should prioritize breast cancer screening now

Breast Cancer Screenings For Women In 40s Could Be Life Saving

breast cancer screenings for women in 40s could be life saving

How To Recognize Symptoms And Prevent Colon Cancer?

how to recognize symptoms and prevent colon cancer?

Parenting

Why Has Kennedy Ordered A Review Of Baby Formula? What Every Parent Must Know About Safety

why has kennedy ordered a review of baby formula? what every parent must know about safety

British pop star Jessie J—best known for her powerhouse vocals and unfiltered honesty recently took to Instagram to share her stage-one breast cancer diagnosis, fans everywhere were left both shocked and motivated. The 37-year-old singer-songwriter, born Jessica Cornish, announced the news in typical frankness, mixing vulnerability with as she explained the surgery she'd be having after performing at Capital's Summertime Ball at London's Wembley Stadium.

Though her confession highlights the psychological burden of battling cancer under the spotlight, it also brings attention to an important discussion: the early warning signs of breast cancer that women so often miss. As a global health epidemic that claims millions of lives each year, breast cancer is more than mere lumps. The initial symptoms are often silent, confused, or ignored—particularly by young women.

In her heartfelt video message, Jessie shared that she has been “in and out of tests” recently and ultimately received a diagnosis of early breast cancer. “Cancer sucks in any form,” she said, “but I’m holding on to the word early.”

With a nod of dark humor, she added, "It's a very dramatic way to get a boob job," vowing followers, "I will come back with massive boobs and more music." But under the humor lay raw emotion and an earnest appeal for sympathy and understanding. "I need to process it and talk about it," she said. "I need a hug."

Having struggled with a string of serious health problems in the past, including a childhood heart condition, a stroke at age 18, Meniere's disease, and even recently being diagnosed with ADHD and OCD, Jessie J is certainly no newcomer to working through health problems. But this latest installment has introduced her to an even more intimate, more personal view.

By disclosing her diagnosis, Jessie J is part of a rising number of public figures using their influence to make health screening and breast cancer discussions more mainstream. Such openness is particularly important in light of the fact that many young women still unrealistically believe breast cancer is an "older woman's disease."

Breast cancer is the most frequently diagnosed cancer in the world and the major cause of cancer death among women, reports the World Health Organization. But even with worldwide awareness efforts, delayed diagnosis remains a big issue. And that delay has part to do with failing to notice—or completely ignore—the warning signs.

<h2>What Are the Signs Women Typically Ignore?</h2>

While a breast lump is usually the most talked-about symptom, breast cancer has many other manifestations. These less common symptoms are important to recognize, particularly for women who might not think of themselves as high-risk.

<h4>1. Swelling in the arm or collarbone area</h4>

A subtle but significant indication is repeated swelling in the underarm or near the collarbone. This can suggest that cancer has spread to the lymph nodes—even when there is as yet no lump in the breast. Although the swelling could be minor or painless, any puffiness that is apparent and does not resolve should be investigated.

<h4>2. Recurring Breast or Chest Pain</h4>

Contrary to what many believe, breast cancer may be painful. Pain that isn't related to your menstrual cycle or physical exertion—particularly sharp, burning, or persistent dull pain—can't be ignored. Although not all breast pain indicates cancer, persistent pain warrants investigation.

<h4>3. Persistent Itchiness and Skin Changes</h4>

Persistent itchiness of the armpit or breast—especially if it is followed by redness, scaling, or swelling—may indicate inflammatory breast cancer, which is a rare but vicious type. Topical remedies that fail and localized itchiness warrant a visit to the doctor.

<h4>4. Persistent, Unexplained Fatigue</h4>

Fatigue is one of the most misdiagnosed symptoms. With the speed of life these days, it's simple to assume tiredness is caused by stress, parenting, or sleeplessness. However, persistent fatigue that is unrelieved by rest could be a sign your body is struggling with an underlying illness, such as cancer.

<h4>5. Inverted Nipple or Nipple Discharge</h4>

Any abrupt nipple changes, like turning inward or flattening, might mean that a tumor is putting pressure on the milk ducts. Similarly, spontaneous nipple discharge, particularly if bloody or unprovoked—must never be left unattended. Such symptoms might appear insignificant but can actually point to significant underlying problems.

Medical experts consistently stress the importance of becoming familiar with your own breast tissue and regularly performing self-exams. According to the UK’s NHS and the American Cancer Society, early detection is the most effective defense. That means not only attending routine mammograms after age 40 (or earlier if you’re high risk) but also being proactive about any bodily changes.

It's not just about finding a lump. It's about recognizing when something doesn't feel right—and trusting yourself enough to speak up.

Jessie J's choice to come forward wasn't for healing herself alone—it was to make others feel less isolated. "I also know how much sharing in the past has helped me," she explained. "People giving me their love and support and also their own stories."

jessie j breast cancer

early breast cancer signs

breast cancer symptoms

celebrity health news

British pop star Jessie J—best known for her powerhouse vocals and unfiltered honesty recently took to Instagram to share her stage-one breast cancer diagnosis, fans everywhere were left both shocked and motivated. The 37-year-old singer-songwriter, born Jessica Cornish, announced the news in typical frankness, mixing vulnerability with as she explained the surgery she'd be having after performing at Capital's Summertime Ball at London's Wembley Stadium.Though her confession highlights the psychological burden of battling cancer under the spotlight, it also brings attention to an important discussion: the early warning signs of breast cancer that women so often miss. As a global health epidemic that claims millions of lives each year, breast cancer is more than mere lumps. The initial symptoms are often silent, confused, or ignored—particularly by young women.In her heartfelt video message, Jessie shared that she has been “in and out of tests” recently and ultimately received a diagnosis of early breast cancer. “Cancer sucks in any form,” she said, “but I’m holding on to the word early.”With a nod of dark humor, she added, "It's a very dramatic way to get a boob job," vowing followers, "I will come back with massive boobs and more music." But under the humor lay raw emotion and an earnest appeal for sympathy and understanding. "I need to process it and talk about it," she said. "I need a hug."Having struggled with a string of serious health problems in the past, including a childhood heart condition, a stroke at age 18, Meniere's disease, and even recently being diagnosed with ADHD and OCD, Jessie J is certainly no newcomer to working through health problems. But this latest installment has introduced her to an even more intimate, more personal view.By disclosing her diagnosis, Jessie J is part of a rising number of public figures using their influence to make health screening and breast cancer discussions more mainstream. Such openness is particularly important in light of the fact that many young women still unrealistically believe breast cancer is an "older woman's disease."Breast cancer is the most frequently diagnosed cancer in the world and the major cause of cancer death among women, reports the World Health Organization. But even with worldwide awareness efforts, delayed diagnosis remains a big issue. And that delay has part to do with failing to notice—or completely ignore—the warning signs.What Are the Signs Women Typically Ignore?While a breast lump is usually the most talked-about symptom, breast cancer has many other manifestations. These less common symptoms are important to recognize, particularly for women who might not think of themselves as high-risk.1. Swelling in the arm or collarbone areaA subtle but significant indication is repeated swelling in the underarm or near the collarbone. This can suggest that cancer has spread to the lymph nodes—even when there is as yet no lump in the breast. Although the swelling could be minor or painless, any puffiness that is apparent and does not resolve should be investigated.2. Recurring Breast or Chest PainContrary to what many believe, breast cancer may be painful. Pain that isn't related to your menstrual cycle or physical exertion—particularly sharp, burning, or persistent dull pain—can't be ignored. Although not all breast pain indicates cancer, persistent pain warrants investigation.3. Persistent Itchiness and Skin ChangesPersistent itchiness of the armpit or breast—especially if it is followed by redness, scaling, or swelling—may indicate inflammatory breast cancer, which is a rare but vicious type. Topical remedies that fail and localized itchiness warrant a visit to the doctor.4. Persistent, Unexplained FatigueFatigue is one of the most misdiagnosed symptoms. With the speed of life these days, it's simple to assume tiredness is caused by stress, parenting, or sleeplessness. However, persistent fatigue that is unrelieved by rest could be a sign your body is struggling with an underlying illness, such as cancer.5. Inverted Nipple or Nipple DischargeAny abrupt nipple changes, like turning inward or flattening, might mean that a tumor is putting pressure on the milk ducts. Similarly, spontaneous nipple discharge, particularly if bloody or unprovoked—must never be left unattended. Such symptoms might appear insignificant but can actually point to significant underlying problems.Medical experts consistently stress the importance of becoming familiar with your own breast tissue and regularly performing self-exams. According to the UK’s NHS and the American Cancer Society, early detection is the most effective defense. That means not only attending routine mammograms after age 40 (or earlier if you’re high risk) but also being proactive about any bodily changes.It's not just about finding a lump. It's about recognizing when something doesn't feel right—and trusting yourself enough to speak up.Jessie J's choice to come forward wasn't for healing herself alone—it was to make others feel less isolated. "I also know how much sharing in the past has helped me," she explained. "People giving me their love and support and also their own stories."